For most patients, depression reflects the combined influence of biological vulnerability, symptom burden, functional ...

Scott Thompson, PhD, discusses psychedelic research at CU Anschutz, real-world Colorado psilocybin outcomes, 5-HT2A ...

Conceptual issues, methodological issues, and findings related to long-term risk of dementia with ECT are discussed.

Trichotillomania and trichophagia are key behavioral drivers of trichobezoar formation; direct questioning about hair ...

In patients with bipolar disorder, SGA-LAI initiation was associated with a shift from acute-care utilization toward ...

This case demonstrates an unusual manifestation of late-life anxiety in which voluntary physical restraint functioned as a ...

Findings from an analysis of 10 studies suggest lithium is effective in preventing postpartum recurrence of mood disorders.

In this letter to the editor, the authors discuss the recent fast-tracking of psychedelic research in the US, noting that ...

In this webinar, Balwinder Singh, MD, and Raman Baweja, MD, describe emerging evidence on GLP-1 receptor agonists for ...

It can also threaten mental health, causing stress and sleep loss. Social Identity Theory explains in-group cohesion and out-group discrimination, contributing to an “us vs. them” mindset. Media and ...

Researchers explored how the antidepressant escitalopram influences brain connectivity, shedding light on why SSRIs take weeks to work. By observing a protein known as synaptic vesicle glycoprotein 2A ...

Clinical relevance: Psilocybin shows promise in treating mood disorders such as PTSD, but carries risks such as serotonin toxicity when used with other drugs. The FDA issued draft guidance in June ...